Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rangering i aksjer #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Aksjekurs
$1.51
Sist synkronisert: 2024-08-26
Markedsverdi
$1.12M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategori

Antall utestående aksjer for Agile Therapeutics, Inc. (AGRX)
Antall utestående aksjer per June 2024: 6.86M
Ifølge Agile Therapeutics, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 6.86M. Ved slutten av December 2022 hadde selskapet 432.22K utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Agile Therapeutics, Inc. (AGRX) fra 2012 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 6.86M 217.90%
2023 2.16M 398.99%
2022 432.22K 35,520.10%
2021 1.21K -97.13%
2020 42.34K 71.31%
2019 24.72K 44.06%
2018 17.16K 10.90%
2017 15.47K 9.44%
2016 14.14K 28.42%
2015 11.01K 93.22%
2014 5.70K 26.21%
2013 4.51K 0.00%
2012 4.51K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter